Laurus Labs Drives Biomanufacturing Growth with ₹160 Crore Investment in Laurus Bio

Introduction
Laurus Labs Limited (BSE: 540222, NSE: LAURUSLABS) has reinforced its commitment to innovation and sustainable manufacturing with a ₹160 crore equity investment in its subsidiary, Laurus Bio. The funding, led by Eight Roads Ventures and F-Prime Capital, marks a significant milestone in Laurus Bio’s growth trajectory, supporting its expansion in microbial fermentation-based manufacturing capabilities and R&D infrastructure.

Details of the Investment
The investment includes ₹120 crore from Eight Roads Ventures and F-Prime Capital, global investors with expertise in biopharmaceuticals and CDMO (Contract Development and Manufacturing Organization) services. Laurus Labs will co-invest an additional ₹40 crore at the same valuation, demonstrating its continued commitment to Laurus Bio’s growth.

Promoters of Laurus Bio have also been issued share warrants, exercisable over two years. Additionally, Laurus Labs or Eight Roads Ventures can invest up to ₹35 crore by December 2025 under the same terms, ensuring flexibility for future funding needs.

Stake Distribution Post-Transaction
Upon completion of the transaction, the equity structure will be as follows:

• Laurus Labs: 75%
• Eight Roads Ventures: 14%
• Promoters of Laurus Bio: 9%

Utilization of Funds
The ₹160 crore equity infusion will be strategically allocated to:

• Expanding fermentation-based manufacturing capabilities.
• Strengthening R&D infrastructure to accelerate product development.
• Enhancing microbial fermentation capabilities for biomanufacturing.

These investments will enable Laurus Bio to cater to growing customer demand across biopharma, food, health, nutrition, and personal care industries.

Laurus Bio: A Rising Biomanufacturing Leader
Laurus Bio Private Limited, a subsidiary of Laurus Labs, is an integrated biomanufacturing organization specializing in precision fermentation and recombinant technology. With over 15 years of experience, Laurus Bio has built a strong reputation for developing ultra-pure, animal-free recombinant products for the biopharma industry.

Its expertise extends to:

• Food and Nutrition: Large-scale production of sustainable bio-based materials.
• Personal Care: Developing innovative ingredients for consumer products.
• Biopharmaceuticals: Meeting global demand for cutting-edge solutions in precision manufacturing.

Strategic Partnership with Eight Roads Ventures
Eight Roads Ventures, a prominent investor in global biopharmaceuticals, has a history of successful partnerships with Laurus Labs and Laurus Bio. This renewed collaboration reflects confidence in Laurus Bio’s potential to lead the microbial fermentation industry.

Dr. Prem Pavoor, Managing Partner at Eight Roads Ventures India, commented:

"We are thrilled to re-unite with Laurus Labs and Laurus Bio. This investment will enable Laurus Bio to expand microbial fermentation capabilities, meet the global demand for sustainable manufacturing, and emerge as a leader in biomanufacturing."

Driving Sustainable Growth
With this funding, Laurus Bio aims to accelerate its journey toward becoming a global leader in sustainable biomanufacturing. Key growth areas include:

• Faster development of innovative products.
• Enhancing internal R&D pipelines.
• Scaling commercial-scale manufacturing to meet global demand.

Conclusion
The ₹160 crore investment in Laurus Bio underscores Laurus Labs’ commitment to advancing sustainable manufacturing technologies and fostering innovation in the biomanufacturing sector. With robust support from Eight Roads Ventures and F-Prime Capital, Laurus Bio is well-positioned to expand its capabilities, deliver cutting-edge solutions, and solidify its global presence.

The Upcoming IPOs in this week and coming weeks are Dhanlaxmi Corp, Jungle Camps, Toss The Coin, Sai Life Sciences, Mobikwik, Vishal Mega Mart, Supreme Facility, Purple United, Rosmerta Digital, Inventurus Knowledge and Avanse Financial.The Current active IPO is Emerald Tyre Manufacturers.For more details on upcoming IPOs, you can visit our page at Best IPO to Apply Now - IPO List 2024, Latest IPO, Upcoming IPO, Recent IPO News, Live IPO GMP Today - Finance Saathi and stay updated with the latest news on IPO updates on Top News Headlines - Share Market News, Latest IPO News, Business News, Economy News - Finance Saathi.Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst & Finance Saathi Telegram Channel for Regular Share Market, News & IPO Updates.Start your Stock Market Journey and Apply in IPO by opening a Free Demat Account in Choice Broking FinX.